MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex-Reference-Cited by-同舟云学术

MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex

Published:2019-06-26 Issue:8 Volume:16 Page:3559-3568
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ku Anthony¹,Chan Conrad¹,Aghevlian Sadaf¹,Cai Zhongli¹,Cescon David,Bratman Scott V.,Ailles Laurie,Hedley David W.,Reilly Raymond M.¹²³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada

2. Department of Medical Imaging, University of Toronto, 263 McCaul Street, Toronto, ON M5T 1W7, Canada

3. Toronto General Research Institute and Joint Department of Medical Imaging, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada

Funder

University of Toronto

Terry Fox Foundation

Natural Sciences and Engineering Research Council of Canada

Canadian Cancer Society Research Institute

Ministry of Research and Innovation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00422